About me
About me
About me
Doctor of Philosophy University of Paris
Masters in Economy and Management of Health Systems University of Paris
Bachelor of Pharmacy University of Paris
Research
Excludes commercial-in-confidence projects.
Optimization and validation of assay of French protocol for phenotyping patient samples for treatment optimization, Pari-Passou Medical Consultancy, 03/08/2020 - 31/12/2020
Evaluation of risks and potential impact of scheduling of ketamine on access on low and middle income countries, World Health Organisation Malaysia, 01/01/2016 - 30/12/2017
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2018 |
2
|
2017 |
8
|
2015 |
6
3
|
2011 |
4
|
Year | Output |
---|---|
2023 |
|
2022 |
Open access
2
2
6
|
2022 |
|
2021 |
1
|
2021 |
Open access
1
2
5
|
2021 |
Open access
1
27
|
2021 |
Open access
|
2020 |
Open access
5
5
2
|
2020 |
3
3
|
2019 |
Open access
18
18
49
|
2019 |
Open access
7
6
14
|
2019 |
Open access
24
22
|
2018 |
Open access
4
5
4
|
2018 |
Open access
7
7
|
2018 |
Open access
24
24
30
|
2018 |
Open access
1
|
2018 |
Open access
14
13
3
|
2018 |
39
37
|
2018 |
1
2
|
2017 |
Open access
15
13
|
2017 |
3
|
2017 |
Open access
21
21
3
|
2017 |
18
16
11
|
2016 |
Open access
11
13
29
|
2016 |
7
6
1
|
2016 |
Open access
15
14
1
|
2016 |
Open access
23
24
4
|
2016 |
Open access
3
2
|
2016 |
2
|
2016 |
Open access
14
9
|
2016 |
113
100
276
|
2015 |
Open access
|
2015 |
Open access
10
10
|
2015 |
Open access
17
14
|
2015 |
Open access
4
2
7
|
2015 |
5
9
|
2015 |
Open access
7
10
|
2014 |
16
13
1
|
2014 |
Open access
31
32
1
|
2014 |
2
1
5
|
2014 |
21
35
10
|
2014 |
Open access
14
12
7
|
2013 |
Open access
42
41
17
|
2013 |
Open access
16
15
3
|
2013 |
15
13
3
|
2013 |
Open access
9
18
|
2012 |
Open access
|
2012 |
Open access
|
2012 |
16
14
4
|
2012 |
8
9
3
|
2011 |
33
24
|
2011 |
17
18
|
2011 |
66
63
|
2011 |
32
|
2011 |
48
41
|
2011 |
10
9
|
2011 |
5
4
|
2010 |
Open access
56
49
|
2010 |
45
42
|
2010 |
Open access
42
37
|
2010 |
130
117
|
2010 |
Open access
27
15
|
2010 |
9
|
2010 |
Open access
15
13
|
2010 |
12
12
|
2010 |
87
74
|
2010 |
Open access
355
297
|
2010 |
18
13
|
2010 |
Open access
32
31
|
2010 |
5
5
|
2010 |
|
2010 |
Open access
22
21
|
2010 |
13
10
|
2009 |
Open access
90
77
|
2009 |
Open access
81
65
|
2009 |
|
2009 |
6
6
|
2009 |
5
4
|
2009 |
Open access
87
81
|
2009 |
1
1
|
2009 |
1
|
2009 |
|
2008 |
Open access
164
141
|
2008 |
24
21
|
2008 |
Open access
76
29
|
2008 |
Vitry, AI 2008, 'Time for Transparency at teh TGA'. |
2008 |
Vitry, AI 2008, 'Time for transparency at the TGA', Australian Prescriber. |
2008 |
23
15
|
2008 |
Open access
7
6
|
Research
External engagement & recognition
Organisation | Country |
---|---|
Alzheimers Australia | AUSTRALIA |
Australian Medicines Handbook Pty Ltd | AUSTRALIA |
Austrian Health Institute | AUSTRIA |
Austrian Medicines and Medical Devices Agency | AUSTRIA |
Consumer Dementia Research Network | AUSTRALIA |
Deakin University | AUSTRALIA |
Dental and Pharmaceuticals Benefits Agency | SWEDEN |
Flinders University | AUSTRALIA |
Harvard University | UNITED STATES |
Health Action International | NETHERLANDS |
Health Authority - Abu Dhabi | UNITED ARAB EMIRATES |
International Islamic University Malaysia | MALAYSIA |
IRDES | FRANCE |
Karolinska Institute | SWEDEN |
Mario Negri Institute for Pharmacological Research | ITALY |
Ministry of Health - Croatia | CROATIA |
Ministry of Health, Republic of Indonesia | INDONESIA |
Monash University | AUSTRALIA |
National Health Insurance Fund | SERBIA |
National University of Malaysia | MALAYSIA |
New Jersey City University | UNITED STATES |
NHS England | UNITED KINGDOM |
NHS Greater Glasgow and Clyde Board HQ | UNITED KINGDOM |
North West Commissioning Support Unit | UNITED KINGDOM |
Princess Alexandra Hospital | AUSTRALIA |
Repatriation General Hospital | AUSTRALIA |
Resthaven Incorporated | AUSTRALIA |
Resthaven Limited | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Cornwall Hospitals NHS Trust | UNITED KINGDOM |
Shandong University | CHINA |
South Australian Health and Medical Research Institute (SAHMRI) | AUSTRALIA |
Taibah University | SAUDI ARABIA |
The University of Notre Dame Australia | AUSTRALIA |
Universiti Kabangsaan Malaysia | MALAYSIA |
University of Aberdeen | UNITED KINGDOM |
University of Adelaide | AUSTRALIA |
University of Auckland | NEW ZEALAND |
University of British Columbia | CANADA |
University of Heidelberg | GERMANY |
University of Helsinki | FINLAND |
University of Huddersfield | UNITED KINGDOM |
University of Lille 2 | FRANCE |
University of Liverpool | UNITED KINGDOM |
University of Otago | NEW ZEALAND |
University of Queensland | AUSTRALIA |
University of Science, Malaysia | MALAYSIA |
University of South Australia | AUSTRALIA |
University of Strathclyde | UNITED KINGDOM |
University of Sydney | AUSTRALIA |
University of Western Australia | AUSTRALIA |
University of York | UNITED KINGDOM |
World Health Organisation | SWITZERLAND |
York University | CANADA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2017 |
MemberInternational Society for Pharmacoepidemiology (ISPE) |
2017 |
MemberHealth Technology Assessment International (HTAi) |
2017 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2016 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2015 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2014 |
Best of the Best Poster Presentation AwardsClinical Oncology Society of Australia |
2013 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2013 |
Invited presentationFlinders Centre for Innovation in Cancer Survivorship Conference |
2013 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2012 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2011 |
Consultant / advisor, Cancer Australia Consumer NetworkCancer Australia, Australian Government |
2010 |
Member, Program Reference Group (implementation and the evaluation of the $731m Fifth Community Agreement between the Commonwealth government and the Pharmacy Guild of Australia)Australian Government |
2010 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Pharmacogenomics to achieve precision dosing of fluoropyrimidines (FP) in cancer patients | Current |
Age and comorbidity: their influence on colorectal cancer stage, treatment and survival in South Australia | Completed |
Assessment of the burden, types and development of comorbidities in the Australian population with cancer | Completed |
Indicators for evaluating medication-related quality of care in Australian residential aged care | Completed |
Quality of information in pharmaceutical promotion | Completed |
The impact of pricing policies on Australia's medicines market | Completed |